Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 1
1987 10
1988 18
1989 17
1990 17
1991 20
1992 29
1993 30
1994 26
1995 28
1996 27
1997 19
1998 27
1999 36
2000 34
2001 32
2002 21
2003 38
2004 29
2005 33
2006 38
2007 43
2008 54
2009 41
2010 49
2011 33
2012 47
2013 54
2014 88
2015 115
2016 114
2017 159
2018 190
2019 206
2020 228
2021 133
Text availability
Article attribute
Article type
Publication date

Search Results

1,891 results
Results by year
Filters applied: . Clear all
Page 1
Glioblastoma.
Wirsching HG, Galanis E, Weller M. Wirsching HG, et al. Handb Clin Neurol. 2016;134:381-97. doi: 10.1016/B978-0-12-802997-8.00023-2. Handb Clin Neurol. 2016. PMID: 26948367 Review.
Glioblastoma is the most common and aggressive primary brain tumor in adults. Defining histopathologic features are necrosis and endothelial proliferation, resulting in the assignment of grade IV, the highest grade in the World Health Organization (WHO) classification of …
Glioblastoma is the most common and aggressive primary brain tumor in adults. Defining histopathologic features are necrosis and endo …
Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?
Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V. Brown PD, et al. J Clin Oncol. 2018 Feb 10;36(5):483-491. doi: 10.1200/JCO.2017.75.9589. Epub 2017 Dec 22. J Clin Oncol. 2018. PMID: 29272161 Free PMC article. Review.
An estimated 20% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone receive whole-brain radiotherapy (WBRT) each year to treat brain metastases. Historically, the prognosis of patients with b
An estimated 20% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone …
Imaging of intratumoral heterogeneity in high-grade glioma.
Hu LS, Hawkins-Daarud A, Wang L, Li J, Swanson KR. Hu LS, et al. Cancer Lett. 2020 May 1;477:97-106. doi: 10.1016/j.canlet.2020.02.025. Epub 2020 Feb 27. Cancer Lett. 2020. PMID: 32112907 Free PMC article. Review.
2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know.
Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ, Kaufmann TJ. Johnson DR, et al. Radiographics. 2017 Nov-Dec;37(7):2164-2180. doi: 10.1148/rg.2017170037. Epub 2017 Oct 13. Radiographics. 2017. PMID: 29028423 Review.
In 2016, the World Health Organization (WHO) released an update to its brain tumor classification system that included numerous significant changes. ...For other tumors, such as medulloblastoma, imaging can demonstrate characteristic patterns that correlate with par …
In 2016, the World Health Organization (WHO) released an update to its brain tumor classification system that included numerous signi …
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF. Sarkaria JN, et al. Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175. Neuro Oncol. 2018. PMID: 29016900 Free PMC article. Review.
The blood-brain barrier (BBB) excludes the vast majority of cancer therapeutics from normal brain. However, the importance of the BBB in limiting drug delivery and efficacy is controversial in high-grade brain tumors, such as glioblastoma (GBM). The ac …
The blood-brain barrier (BBB) excludes the vast majority of cancer therapeutics from normal brain. However, the importance of …
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.
Schiff D, Van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY. Schiff D, et al. Neuro Oncol. 2019 Jul 11;21(7):837-853. doi: 10.1093/neuonc/noz033. Neuro Oncol. 2019. PMID: 30753579 Free PMC article. Review.
The finding that most grades II and III gliomas harbor isocitrate dehydrogenase (IDH) mutations conveying a relatively favorable and fairly similar prognosis in both tumor grades highlights that these tumors represent a fundamentally different entity from IDH wild-type gli …
The finding that most grades II and III gliomas harbor isocitrate dehydrogenase (IDH) mutations conveying a relatively favorable and fairly …
Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases.
Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP, Lo SS, Mahajan A, Oh KS, Sheehan JP, Soltys SG, Sahgal A. Soliman H, et al. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):436-442. doi: 10.1016/j.ijrobp.2017.09.047. Epub 2017 Oct 4. Int J Radiat Oncol Biol Phys. 2018. PMID: 29157748
PURPOSE: To propose contouring guidelines based on consensus contours generated by 10 international experts for cavity stereotactic radiosurgery (SRS), an emerging treatment option after surgical resection of brain metastases. No guidelines for contouring the surgical cavi …
PURPOSE: To propose contouring guidelines based on consensus contours generated by 10 international experts for cavity stereotactic radiosur …
Imaging of fetal brain tumors.
Cornejo P, Feygin T, Vaughn J, Pfeifer CM, Korostyshevska A, Patel M, Bardo DME, Miller J, Goncalves LF. Cornejo P, et al. Pediatr Radiol. 2020 Dec;50(13):1959-1973. doi: 10.1007/s00247-020-04777-z. Epub 2020 Nov 30. Pediatr Radiol. 2020. PMID: 33252762 Review.
Congenital brain tumors, defined as those diagnosed prenatally or within the first 2 months of age, represent less than 2% of pediatric brain tumors. ...In this review, we summarize the pathogenesis, diagnosis, management and prognosis of the most freq …
Congenital brain tumors, defined as those diagnosed prenatally or within the first 2 months of age, represent less than 2% of …
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.
Louis DN, Giannini C, Capper D, Paulus W, Figarella-Branger D, Lopes MB, Batchelor TT, Cairncross JG, van den Bent M, Wick W, Wesseling P. Louis DN, et al. Acta Neuropathol. 2018 Apr;135(4):639-642. doi: 10.1007/s00401-018-1826-y. Epub 2018 Mar 1. Acta Neuropathol. 2018. PMID: 29497819 No abstract available.
1,891 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page